European guidelines on managing adverse effects of medication for ADHD

J. Graham (Lead / Corresponding author), T. Banaschewski, J. Buitelaar, D. Coghill, M. Danckaerts, Ralf W Dittmann, M. Doepfner, R. Hamilton, C. Hollis, M. Holtmann, M. Hulpke-Wette, M. Lecendreux, E. Rosenthal, A. Rothenberger, P. Santosh, J. Sergeant, E. Simonoff, E. Sonuga-Barke, I. C. K. Wong, A. ZuddasH. -C. Steinhausen, E. Taylor, European Guidelines Grp

    Research output: Contribution to journalArticle

    241 Citations (Scopus)

    Abstract

    The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemporary-standard information about medications first licensed several decades ago, and signals of possible harm arising from more recently developed medications. These relate to both relatively minor adverse effects and extremely serious issues such as sudden cardiac death and suicidality. A guidelines group of the European Network for Hyperkinetic Disorders (EUNETHYDIS) has therefore reviewed the literature, recruited renowned clinical sub-specialists and consulted as a group to examine these concerns. Some of the effects examined appeared to be minimal in impact or difficult to distinguish from risk to untreated populations. However, several areas require further study to allow a more precise understanding of these risks.

    Original languageEnglish
    Pages (from-to)17-37
    Number of pages21
    JournalEuropean Child & Adolescent Psychiatry
    Volume20
    Issue number1
    DOIs
    Publication statusPublished - Jan 2011

    Keywords

    • ADHD
    • HKS
    • Medication
    • Adverse
    • Guidelines
    • European
    • Children
    • ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER
    • DEFICIT-HYPERACTIVITY DISORDER
    • SUBSTANCE USE DISORDERS
    • SUDDEN CARDIAC DEATH
    • RANDOMIZED CONTROLLED-TRIAL
    • COMORBID TIC DISORDERS
    • PEDIATRIC BURN INJURY
    • PROSPECTIVE FOLLOW-UP
    • OF-THE-LITERATURE
    • YOUNG-ADULTS

    Cite this

    Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Doepfner, M., Hamilton, R., Hollis, C., Holtmann, M., Hulpke-Wette, M., Lecendreux, M., Rosenthal, E., Rothenberger, A., Santosh, P., Sergeant, J., Simonoff, E., Sonuga-Barke, E., Wong, I. C. K., ... European Guidelines Grp (2011). European guidelines on managing adverse effects of medication for ADHD. European Child & Adolescent Psychiatry, 20(1), 17-37. https://doi.org/10.1007/s00787-010-0140-6